Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer.

Cancers (Basel) · 2023 · PMC9913370 · PMID 36765627

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The timing of immunotherapy in relation to the other cancer treatments may be significant as well, in that the initial suppressive immune microenvironment after surgery can be replaced via cytoreductive therapies (such as radiation or chemotherapy) and enhanced with immunotherapy after adequate immune recovery [ 14 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.